메뉴 건너뛰기




Volumn 24, Issue 6, 2012, Pages 503-512

Intestinal barrier function in health and gastrointestinal disease

Author keywords

Glutamine; Intestinal barrier; Irritable bowel syndrome; MicroRNA; Tight junction proteins

Indexed keywords

ACTIN; CLAUDIN; CLAUDIN 1; CLAUDIN 10; CLAUDIN 2; CLAUDIN 3; CLAUDIN 4; CLAUDIN 5; CLAUDIN 7; CLAUDIN 8; GLUTAMATE AMMONIA LIGASE; GLUTAMINE; LACTULOSE; MANNITOL; MEMBRANE PROTEIN; OCCLUDIN; PROTEIN ZO1; PROTEIN ZO2; PROTEIN ZO3; SUCROSE; UNCLASSIFIED DRUG;

EID: 84861170097     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2012.01921.x     Document Type: Review
Times cited : (662)

References (82)
  • 1
    • 77953243617 scopus 로고    scopus 로고
    • The intestinal barrier and its regulation by neuroimmune factors
    • Keita AV, Söderholm JD. The intestinal barrier and its regulation by neuroimmune factors. Neurogastroenterol Motil 2010; 22: 718-33.
    • (2010) Neurogastroenterol Motil , vol.22 , pp. 718-733
    • Keita, A.V.1    Söderholm, J.D.2
  • 2
    • 77958170401 scopus 로고    scopus 로고
    • Intestinal goblet cells and mucins in health and disease: recent insights and progress
    • Kim YS, Ho SB. Intestinal goblet cells and mucins in health and disease: recent insights and progress. Curr Gastroenterol Rep 2010; 12: 319-30.
    • (2010) Curr Gastroenterol Rep , vol.12 , pp. 319-330
    • Kim, Y.S.1    Ho, S.B.2
  • 3
    • 0036406590 scopus 로고    scopus 로고
    • Bacteriocins: evolution, ecology, and application
    • Riley MA, Wertz JE. Bacteriocins: evolution, ecology, and application. Annu Rev Microbiol 2002; 56: 117-37.
    • (2002) Annu Rev Microbiol , vol.56 , pp. 117-137
    • Riley, M.A.1    Wertz, J.E.2
  • 4
    • 79954915318 scopus 로고    scopus 로고
    • Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis
    • Bevins CL, Salzmann NH. Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat Rev Microbiol 2011; 9: 356-68.
    • (2011) Nat Rev Microbiol , vol.9 , pp. 356-368
    • Bevins, C.L.1    Salzmann, N.H.2
  • 5
    • 0035026232 scopus 로고    scopus 로고
    • The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo
    • Atuma C, Strugala V, Allen A, Holm L. The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. Am J Physiol 2001; 280: G922-9.
    • (2001) Am J Physiol , vol.280
    • Atuma, C.1    Strugala, V.2    Allen, A.3    Holm, L.4
  • 6
    • 71649100500 scopus 로고    scopus 로고
    • Analysis of unstirred water layer in vitro permeability experiments
    • Korjamo T, Heikkinen AT, Mönkkönen J. Analysis of unstirred water layer in vitro permeability experiments. J Pharm Sci 2009; 98: 4469-79.
    • (2009) J Pharm Sci , vol.98 , pp. 4469-4479
    • Korjamo, T.1    Heikkinen, A.T.2    Mönkkönen, J.3
  • 7
    • 2142813761 scopus 로고    scopus 로고
    • A porous defense: the leaky epithelial barrier in intestinal disease
    • Clayburgh DR, Shen L, Turner JR. A porous defense: the leaky epithelial barrier in intestinal disease. Lab Invest 2004; 84: 282-91.
    • (2004) Lab Invest , vol.84 , pp. 282-291
    • Clayburgh, D.R.1    Shen, L.2    Turner, J.R.3
  • 8
    • 67249096227 scopus 로고    scopus 로고
    • Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms
    • Visser J, Rozing J, Sapone A, Lammers K, Fasano A. Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms. Ann NY Acad Sci 2009; 1165: 95-205.
    • (2009) Ann NY Acad Sci , vol.1165 , pp. 95-205
    • Visser, J.1    Rozing, J.2    Sapone, A.3    Lammers, K.4    Fasano, A.5
  • 9
    • 0024593744 scopus 로고
    • Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability
    • Hildalgo IJ, Raub TJ, Borchardt RT. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 1989; 96: 736-49.
    • (1989) Gastroenterology , vol.96 , pp. 736-749
    • Hildalgo, I.J.1    Raub, T.J.2    Borchardt, R.T.3
  • 11
    • 70350509805 scopus 로고    scopus 로고
    • Intestinal mucosal barrier function in health and disease
    • Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 2009; 9: 799-809.
    • (2009) Nat Rev Immunol , vol.9 , pp. 799-809
    • Turner, J.R.1
  • 12
    • 78751699186 scopus 로고    scopus 로고
    • Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer
    • Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev 2011; 91: 151-75.
    • (2011) Physiol Rev , vol.91 , pp. 151-175
    • Fasano, A.1
  • 13
    • 77952536060 scopus 로고    scopus 로고
    • Segmental expression of claudin proteins correlates with tight junction barrier properties in rat intestine
    • Veshnyakova A, Fromm M, Amasheh M, Amasheh S. Segmental expression of claudin proteins correlates with tight junction barrier properties in rat intestine. J Comp Physiol B 2010; 180: 591-8.
    • (2010) J Comp Physiol B , vol.180 , pp. 591-598
    • Veshnyakova, A.1    Fromm, M.2    Amasheh, M.3    Amasheh, S.4
  • 14
    • 33749186777 scopus 로고    scopus 로고
    • Alterations in intestinal permeability
    • Arrieta MC, Bistritz L, Meddings JB. Alterations in intestinal permeability. Gut 2006; 55: 1512-20.
    • (2006) Gut , vol.55 , pp. 1512-1520
    • Arrieta, M.C.1    Bistritz, L.2    Meddings, J.B.3
  • 15
    • 58849136276 scopus 로고    scopus 로고
    • Impaired intestinal barrier integrity in the colon of irritable bowel syndrome patients: involvement of soluble mediators
    • Piche T, Barbara G, Aubert P et al. Impaired intestinal barrier integrity in the colon of irritable bowel syndrome patients: involvement of soluble mediators. Gut 2009; 58: 196-201.
    • (2009) Gut , vol.58 , pp. 196-201
    • Piche, T.1    Barbara, G.2    Aubert, P.3
  • 16
    • 77957929507 scopus 로고    scopus 로고
    • Subjects with diarrhea-predominant IBS have increased rectal permeability responsive to tryptase
    • Lee JW, Park JH, Park DI et al. Subjects with diarrhea-predominant IBS have increased rectal permeability responsive to tryptase. Dig Dis Sci 2010; 55: 2922-8.
    • (2010) Dig Dis Sci , vol.55 , pp. 2922-2928
    • Lee, J.W.1    Park, J.H.2    Park, D.I.3
  • 17
    • 77953721053 scopus 로고    scopus 로고
    • MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome
    • Zhou Q, Souba WW, Croce CM, Verne GN. MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome. Gut 2010; 59: 775-84.
    • (2010) Gut , vol.59 , pp. 775-784
    • Zhou, Q.1    Souba, W.W.2    Croce, C.M.3    Verne, G.N.4
  • 18
    • 79960704872 scopus 로고    scopus 로고
    • Measuring size-dependent permeability of the tight junction using PEG profiling
    • Van Itallie CM, Anderson JM. Measuring size-dependent permeability of the tight junction using PEG profiling. Methods Mol Biol 2011; 762: 1-11.
    • (2011) Methods Mol Biol , vol.762 , pp. 1-11
    • Van Itallie, C.M.1    Anderson, J.M.2
  • 19
    • 79960709574 scopus 로고    scopus 로고
    • Electrophysiological characterization of claudin ion permeability using stably transfected epithelial cell lines
    • Yu AS. Electrophysiological characterization of claudin ion permeability using stably transfected epithelial cell lines. Methods Mol Biol 2011; 762: 27-41.
    • (2011) Methods Mol Biol , vol.762 , pp. 27-41
    • Yu, A.S.1
  • 21
    • 34250877518 scopus 로고    scopus 로고
    • Intestinal permeability and irritable bowel syndrome
    • Camilleri M, Gorman H. Intestinal permeability and irritable bowel syndrome. Neurogastroenterol Motil 2007; 19: 545-52.
    • (2007) Neurogastroenterol Motil , vol.19 , pp. 545-552
    • Camilleri, M.1    Gorman, H.2
  • 23
    • 0031961990 scopus 로고    scopus 로고
    • Discrimination of site-specific alterations in gastrointestinal permeability in the rat
    • Meddings JB, Gibbons I. Discrimination of site-specific alterations in gastrointestinal permeability in the rat. Gastroenterology 1998; 114: 83-92.
    • (1998) Gastroenterology , vol.114 , pp. 83-92
    • Meddings, J.B.1    Gibbons, I.2
  • 24
    • 80055048012 scopus 로고    scopus 로고
    • Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls
    • Aug 11. doi:
    • Rao AS, Camilleri M, Eckert DJ et al. Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls. Am J Physiol 2011; 301: G919-28. Aug 11. doi:
    • (2011) Am J Physiol , vol.301
    • Rao, A.S.1    Camilleri, M.2    Eckert, D.J.3
  • 25
    • 0142150993 scopus 로고    scopus 로고
    • Human ENS regulates the intestinal epithelial barrier permeability and a tight junction-association protein Z)-1 via VIPergic pathways
    • Neunlist M, Toumi F, Oreschkova T et al. Human ENS regulates the intestinal epithelial barrier permeability and a tight junction-association protein Z)-1 via VIPergic pathways. Am J Physiol Gastrointestin Liver Physiol 2003; 285: G1028-36.
    • (2003) Am J Physiol Gastrointestin Liver Physiol , vol.285
    • Neunlist, M.1    Toumi, F.2    Oreschkova, T.3
  • 26
    • 24744432512 scopus 로고    scopus 로고
    • Mast cell tryptase controls paracellular permeability of the intestine Role of protease-activated receptor 2 and beta-arrestins
    • Jacob C, Yang PC, Darmoul D et al. Mast cell tryptase controls paracellular permeability of the intestine Role of protease-activated receptor 2 and beta-arrestins. J Biol Chem 2005; 280: 31936-48.
    • (2005) J Biol Chem , vol.280 , pp. 31936-31948
    • Jacob, C.1    Yang, P.C.2    Darmoul, D.3
  • 27
    • 43749087805 scopus 로고    scopus 로고
    • Protease-activated receptor 2 and gut permeability: a review
    • Bueno L, Fioramonti J. Protease-activated receptor 2 and gut permeability: a review. Neurogastroenterol Motil 2008; 20: 580-7.
    • (2008) Neurogastroenterol Motil , vol.20 , pp. 580-587
    • Bueno, L.1    Fioramonti, J.2
  • 28
    • 0242332769 scopus 로고    scopus 로고
    • Proteinase-mediated signaling: proteinase-activated receptors (PARs) and much more
    • Hollenberg MD. Proteinase-mediated signaling: proteinase-activated receptors (PARs) and much more. Life Sci 2003; 74: 237-46.
    • (2003) Life Sci , vol.74 , pp. 237-246
    • Hollenberg, M.D.1
  • 29
    • 79251567978 scopus 로고    scopus 로고
    • The active Zot domain (aa 288-293) increases ZO-1 and myosin 1C serine/threonine phosphorylation, alters interaction betnween ZO-1 and its binding partners, and induces tight junction disassembly through proteinase activated receptor 2 activation
    • Goldblum SE, Rai U, Tripathi A et al. The active Zot domain (aa 288-293) increases ZO-1 and myosin 1C serine/threonine phosphorylation, alters interaction betnween ZO-1 and its binding partners, and induces tight junction disassembly through proteinase activated receptor 2 activation. FASEB J 2011; 25: 144-58.
    • (2011) FASEB J , vol.25 , pp. 144-158
    • Goldblum, S.E.1    Rai, U.2    Tripathi, A.3
  • 30
    • 57349107080 scopus 로고    scopus 로고
    • Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function
    • Ewaschuk J, Diaz H, Meddings L et al. Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am J Physiol 2008; 295: G1025-34.
    • (2008) Am J Physiol , vol.295
    • Ewaschuk, J.1    Diaz, H.2    Meddings, L.3
  • 31
    • 44949153787 scopus 로고    scopus 로고
    • Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity
    • Ukena S, Singh A, Dringenberg U et al. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS Biol 2007; 2: e1308.
    • (2007) PLoS Biol , vol.2
    • Ukena, S.1    Singh, A.2    Dringenberg, U.3
  • 32
    • 78649802133 scopus 로고    scopus 로고
    • Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation
    • Anderson RC, Cookson AL, McNabb WC et al. Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation. BMC Microbiol 2010; 10: 316.
    • (2010) BMC Microbiol , vol.10 , pp. 316
    • Anderson, R.C.1    Cookson, A.L.2    McNabb, W.C.3
  • 33
    • 0029161839 scopus 로고
    • Zonula occludens toxin modulates tight junctions through protein kinase C-dependent actin reorganization, in vitro
    • Fasano A, Fiorentini C, Donelli G et al. Zonula occludens toxin modulates tight junctions through protein kinase C-dependent actin reorganization, in vitro. J Clin Invest 1995; 96: 710-20.
    • (1995) J Clin Invest , vol.96 , pp. 710-720
    • Fasano, A.1    Fiorentini, C.2    Donelli, G.3
  • 34
    • 34247235029 scopus 로고    scopus 로고
    • Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function
    • Cario E, Gerken G, Podolsky DK. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 2007; 132: 1359-74.
    • (2007) Gastroenterology , vol.132 , pp. 1359-1374
    • Cario, E.1    Gerken, G.2    Podolsky, D.K.3
  • 35
    • 76249101130 scopus 로고    scopus 로고
    • The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation
    • Bansal T, Alaniz RC, Wood TK, Jayaraman A. The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation. Proc Natl Acad Sci USA 2010; 107: 228-33.
    • (2010) Proc Natl Acad Sci USA , vol.107 , pp. 228-233
    • Bansal, T.1    Alaniz, R.C.2    Wood, T.K.3    Jayaraman, A.4
  • 36
    • 79251584066 scopus 로고    scopus 로고
    • Bifidobacteria can protect from enteropathogenic infection through production of acetate
    • Fukuda S, Toh H, Hase K et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 2011; 469: 543-7.
    • (2011) Nature , vol.469 , pp. 543-547
    • Fukuda, S.1    Toh, H.2    Hase, K.3
  • 37
    • 37149022209 scopus 로고    scopus 로고
    • Review article: the role of butyrate on colonic function
    • Hamer HM, Jonkers D, Venema K et al. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 2008; 27: 104-19.
    • (2008) Aliment Pharmacol Ther , vol.27 , pp. 104-119
    • Hamer, H.M.1    Jonkers, D.2    Venema, K.3
  • 39
    • 67249115274 scopus 로고    scopus 로고
    • Modulation of intestinal barrier properties by probiotics: role in reversing colitis
    • Resta-Lenert SC, Barrett KE. Modulation of intestinal barrier properties by probiotics: role in reversing colitis. Ann NY Acad Sci 2009; 1165: 175-82.
    • (2009) Ann NY Acad Sci , vol.1165 , pp. 175-182
    • Resta-Lenert, S.C.1    Barrett, K.E.2
  • 40
    • 58249085436 scopus 로고    scopus 로고
    • Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse
    • Arrieta MC, Madsen K, Doyle J, Meddings J. Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse. Gut 2009; 58: 41-8.
    • (2009) Gut , vol.58 , pp. 41-48
    • Arrieta, M.C.1    Madsen, K.2    Doyle, J.3    Meddings, J.4
  • 41
    • 58649090901 scopus 로고    scopus 로고
    • Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis
    • Su L, Shen L, Clayburgh DR et al. Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis. Gastroenterology 2009; 136: 551-63.
    • (2009) Gastroenterology , vol.136 , pp. 551-563
    • Su, L.1    Shen, L.2    Clayburgh, D.R.3
  • 42
    • 24144465134 scopus 로고    scopus 로고
    • Epithelial barrier function in vivo is sustained despite gaps in epithelial layers
    • Watson AJ, Chu S, Sieck L et al. Epithelial barrier function in vivo is sustained despite gaps in epithelial layers. Gastroenterology 2005; 129: 902-12.
    • (2005) Gastroenterology , vol.129 , pp. 902-912
    • Watson, A.J.1    Chu, S.2    Sieck, L.3
  • 43
    • 84861141814 scopus 로고    scopus 로고
    • Epithelial gaps in a rodent model of inflammatory bowel disease: a quantitative validation study
    • Liu JJ RJ, Mah SJ, Thiesen AL et al. Epithelial gaps in a rodent model of inflammatory bowel disease: a quantitative validation study. Clin Transl Gastroenterol 2011; 2: e3.
    • (2011) Clin Transl Gastroenterol , vol.2
    • Liu, J.R.1    Mah, S.J.2    Thiesen, A.L.3
  • 44
    • 36549065297 scopus 로고    scopus 로고
    • Identification of epithelial gaps in human small and large intestine by confocal endomicroscopy
    • Kiesslich R, Goetz M, Angus EM et al. Identification of epithelial gaps in human small and large intestine by confocal endomicroscopy. Gastroenterology 2007; 133: 1769-78.
    • (2007) Gastroenterology , vol.133 , pp. 1769-1778
    • Kiesslich, R.1    Goetz, M.2    Angus, E.M.3
  • 45
    • 79958816432 scopus 로고    scopus 로고
    • Paracellular permeability is increased by basal lipopolysaccharide in a primary culture of colonic epithelial cells; an effect prevented by an activator of Toll-like receptor-2
    • Hanson PJ, Moran AP, Butler K. Paracellular permeability is increased by basal lipopolysaccharide in a primary culture of colonic epithelial cells; an effect prevented by an activator of Toll-like receptor-2. Innate Immun 2011; 17: 269-82.
    • (2011) Innate Immun , vol.17 , pp. 269-282
    • Hanson, P.J.1    Moran, A.P.2    Butler, K.3
  • 46
    • 0027338122 scopus 로고
    • Intestinal permeability to [51Cr]EDTA in infectious diarrhea
    • Zuckerman MJ, Watts MT, Bhatt BD, Ho H. Intestinal permeability to [51Cr]EDTA in infectious diarrhea. Dig Dis Sci 1993; 38: 1651-7.
    • (1993) Dig Dis Sci , vol.38 , pp. 1651-1657
    • Zuckerman, M.J.1    Watts, M.T.2    Bhatt, B.D.3    Ho, H.4
  • 47
    • 0033665517 scopus 로고    scopus 로고
    • Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome
    • Spiller RC, Jenkins D, Thornley JP et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000; 47: 804-11.
    • (2000) Gut , vol.47 , pp. 804-811
    • Spiller, R.C.1    Jenkins, D.2    Thornley, J.P.3
  • 48
    • 11144330063 scopus 로고    scopus 로고
    • Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario
    • Marshall JK, Thabane M, Garg AX et al. Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario. Aliment Pharmacol Ther 2004; 20: 1317-22.
    • (2004) Aliment Pharmacol Ther , vol.20 , pp. 1317-1322
    • Marshall, J.K.1    Thabane, M.2    Garg, A.X.3
  • 49
    • 77949833947 scopus 로고    scopus 로고
    • Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis
    • Villani AC, Lemire M, Thabane M et al. Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis. Gastroenterology 2010; 138: 1502-13.
    • (2010) Gastroenterology , vol.138 , pp. 1502-1513
    • Villani, A.C.1    Lemire, M.2    Thabane, M.3
  • 50
    • 70649113728 scopus 로고    scopus 로고
    • Common variants at five new loci associated with early-onset inflammatory bowel disease
    • Imielinski M, Baldassano RN, Griffiths A et al. Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet 2009; 41: 1335-40.
    • (2009) Nat Genet , vol.41 , pp. 1335-1340
    • Imielinski, M.1    Baldassano, R.N.2    Griffiths, A.3
  • 51
    • 84861125113 scopus 로고    scopus 로고
    • Identifying and testing candidate genes underlying the inflammatory basis of irritable bowel syndrome
    • Spiller R, Swan C, Campbell E et al. Identifying and testing candidate genes underlying the inflammatory basis of irritable bowel syndrome. Gut 2011; 60: A164.
    • (2011) Gut , vol.60
    • Spiller, R.1    Swan, C.2    Campbell, E.3
  • 52
    • 84873074351 scopus 로고    scopus 로고
    • Association of TNFSF15 polymorphism with irritable bowel syndrome
    • Zucchelli M, Camilleri M, Nixon AA et al. Association of TNFSF15 polymorphism with irritable bowel syndrome. Gut 2011; 41: 134-40.
    • (2011) Gut , vol.41 , pp. 134-140
    • Zucchelli, M.1    Camilleri, M.2    Nixon, A.A.3
  • 53
    • 33646270193 scopus 로고    scopus 로고
    • Phenotypic changes in colonocytes following acute stress or activation of mast cells in mice: implications for delayed epithelial barrier dysfunction
    • Demaude J, Salvador-Cartier C, Fioramonti J et al. Phenotypic changes in colonocytes following acute stress or activation of mast cells in mice: implications for delayed epithelial barrier dysfunction. Gut 2006; 55: 655-61.
    • (2006) Gut , vol.55 , pp. 655-661
    • Demaude, J.1    Salvador-Cartier, C.2    Fioramonti, J.3
  • 54
    • 33744830627 scopus 로고    scopus 로고
    • Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes
    • Dunlop SP, Hebden J, Campbell E et al. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am J Gastroenterol 2006; 101: 1288-94.
    • (2006) Am J Gastroenterol , vol.101 , pp. 1288-1294
    • Dunlop, S.P.1    Hebden, J.2    Campbell, E.3
  • 55
    • 70349327608 scopus 로고    scopus 로고
    • The relationship between small-intestinal bacterial overgrowth and intestinal permeability in patients with irritable bowel syndrome
    • Park JH, Park DI, Kim HJ et al. The relationship between small-intestinal bacterial overgrowth and intestinal permeability in patients with irritable bowel syndrome. Gut 2009; 3: 174-9.
    • (2009) Gut , vol.3 , pp. 174-179
    • Park, J.H.1    Park, D.I.2    Kim, H.J.3
  • 56
    • 78649987442 scopus 로고    scopus 로고
    • Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery - a double-blind study
    • Liu Z, Qin H, Yang Z et al. Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery - a double-blind study. Aliment Pharmacol Ther 2011; 33: 50-63.
    • (2011) Aliment Pharmacol Ther , vol.33 , pp. 50-63
    • Liu, Z.1    Qin, H.2    Yang, Z.3
  • 57
    • 52149114013 scopus 로고    scopus 로고
    • Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome
    • Zeng J, Li YQ, Zuo XL et al. Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2008; 28: 994-1002.
    • (2008) Aliment Pharmacol Ther , vol.28 , pp. 994-1002
    • Zeng, J.1    Li, Y.Q.2    Zuo, X.L.3
  • 58
    • 67650523807 scopus 로고    scopus 로고
    • Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof of concept study
    • Corinaldesi R, Stanghellini V, Cremon C et al. Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof of concept study. Aliment Pharmacol Ther 2009; 30: 245-52.
    • (2009) Aliment Pharmacol Ther , vol.30 , pp. 245-252
    • Corinaldesi, R.1    Stanghellini, V.2    Cremon, C.3
  • 59
    • 77951975962 scopus 로고    scopus 로고
    • Increased proteasome-mediated degradation of occludin in irritable bowel syndrome
    • Coeffier M, Gloro R, Boukhettala N et al. Increased proteasome-mediated degradation of occludin in irritable bowel syndrome. Am J Gastroenterol 2010; 105: 1181-8.
    • (2010) Am J Gastroenterol , vol.105 , pp. 1181-1188
    • Coeffier, M.1    Gloro, R.2    Boukhettala, N.3
  • 60
    • 82955233025 scopus 로고    scopus 로고
    • The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype
    • Bertiaux-Vandaele N, Youmba SB, Belmonte L et al. The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype. Am J Gastroenterol 2011; 106: 2165-73.
    • (2011) Am J Gastroenterol , vol.106 , pp. 2165-2173
    • Bertiaux-Vandaele, N.1    Youmba, S.B.2    Belmonte, L.3
  • 61
    • 69849112958 scopus 로고    scopus 로고
    • Expression of catalytic proteasome subunits in the gut of patients with Crohn's disease
    • Visekruna A, Slavova N, Dullat S et al. Expression of catalytic proteasome subunits in the gut of patients with Crohn's disease. Int J Colorectal Dis 2009; 24: 1133-9.
    • (2009) Int J Colorectal Dis , vol.24 , pp. 1133-1139
    • Visekruna, A.1    Slavova, N.2    Dullat, S.3
  • 62
    • 0031899530 scopus 로고    scopus 로고
    • Release of mast cell mediators into the jejunum by cold pain stress in humans
    • Santos J, Saperas E, Nogueiras C et al. Release of mast cell mediators into the jejunum by cold pain stress in humans. Gastroenterology 1998; 114: 640-8.
    • (1998) Gastroenterology , vol.114 , pp. 640-648
    • Santos, J.1    Saperas, E.2    Nogueiras, C.3
  • 63
    • 10744225624 scopus 로고    scopus 로고
    • Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome
    • Barbara G, Stanghellini V, De Giorgio R et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004; 126: 693-702.
    • (2004) Gastroenterology , vol.126 , pp. 693-702
    • Barbara, G.1    Stanghellini, V.2    De Giorgio, R.3
  • 64
    • 41149133760 scopus 로고    scopus 로고
    • Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome
    • Piche T, Saint-Paul MC, Dainese R et al. Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome. Gut 2008; 57: 468-73.
    • (2008) Gut , vol.57 , pp. 468-473
    • Piche, T.1    Saint-Paul, M.C.2    Dainese, R.3
  • 65
    • 3242680477 scopus 로고    scopus 로고
    • Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis
    • Wang LH, Fang XC, Pan GZ. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut 2004; 53: 1096-101.
    • (2004) Gut , vol.53 , pp. 1096-1101
    • Wang, L.H.1    Fang, X.C.2    Pan, G.Z.3
  • 66
    • 33846989359 scopus 로고    scopus 로고
    • Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum
    • Guilarte M, Santos J, deTorres I et al. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut 2007; 56: 203-9.
    • (2007) Gut , vol.56 , pp. 203-209
    • Guilarte, M.1    Santos, J.2    deTorres, I.3
  • 67
    • 79955383575 scopus 로고    scopus 로고
    • Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation
    • Foley S, Garsed K, Singh G et al. Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation. Gastroenterology 2011; 140: 1434-43.
    • (2011) Gastroenterology , vol.140 , pp. 1434-1443
    • Foley, S.1    Garsed, K.2    Singh, G.3
  • 68
    • 38349087186 scopus 로고    scopus 로고
    • Corticotropin-releasing hormone (CRH) regulates macromolecular permeability via mast cells in normal human colonic biopsies in vitro
    • Wallon C, Yang PC, Keita AV et al. Corticotropin-releasing hormone (CRH) regulates macromolecular permeability via mast cells in normal human colonic biopsies in vitro. Gut 2008; 57: 50-8.
    • (2008) Gut , vol.57 , pp. 50-58
    • Wallon, C.1    Yang, P.C.2    Keita, A.V.3
  • 69
    • 59749092589 scopus 로고    scopus 로고
    • Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome
    • Langhorst J, Junge A, Rueffer A et al. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome. Am J Gastroenterol 2009; 104: 404-10.
    • (2009) Am J Gastroenterol , vol.104 , pp. 404-410
    • Langhorst, J.1    Junge, A.2    Rueffer, A.3
  • 70
    • 70349799526 scopus 로고    scopus 로고
    • Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome
    • Zhou Q, Zhang B, Verne GN. Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome. Pain 2009; 146: 41-6.
    • (2009) Pain , vol.146 , pp. 41-46
    • Zhou, Q.1    Zhang, B.2    Verne, G.N.3
  • 71
    • 0025069211 scopus 로고
    • The importance of intestinal glutamine metabolism in maintaining a healthy gastrointestinal tract and supporting the body's response to injury and illness
    • Klimberg VA, Souba WW. The importance of intestinal glutamine metabolism in maintaining a healthy gastrointestinal tract and supporting the body's response to injury and illness. Surg Annu 1990; 22: 61-76.
    • (1990) Surg Annu , vol.22 , pp. 61-76
    • Klimberg, V.A.1    Souba, W.W.2
  • 73
    • 0025365987 scopus 로고
    • The role of glutamine in maintaning a healthy gut and supporting the metabolic response to injury and infection
    • Souba WW, Klimberg VS, Plumley DA et al. The role of glutamine in maintaning a healthy gut and supporting the metabolic response to injury and infection. J Surg Res 1990; 48: 383-91.
    • (1990) J Surg Res , vol.48 , pp. 383-391
    • Souba, W.W.1    Klimberg, V.S.2    Plumley, D.A.3
  • 74
    • 0031879722 scopus 로고    scopus 로고
    • Effects of glutamine supplements and radiochemotherapy on the systemic immune and gut barrier function in patients with advanced esophageal cancer
    • Yoshida S, Matsui M, Shirouzu Y et al. Effects of glutamine supplements and radiochemotherapy on the systemic immune and gut barrier function in patients with advanced esophageal cancer. Ann Surg 1998; 227: 485-91.
    • (1998) Ann Surg , vol.227 , pp. 485-491
    • Yoshida, S.1    Matsui, M.2    Shirouzu, Y.3
  • 75
    • 33846952142 scopus 로고    scopus 로고
    • Low intestinal glutamine level and low glutaminase activity in Crohn's Disease: a rational for glutamine supplementation?
    • Sido B, Seel C, Hochlehnert A et al. Low intestinal glutamine level and low glutaminase activity in Crohn's Disease: a rational for glutamine supplementation? Dig Dis Sci 2006; 51: 2170-9.
    • (2006) Dig Dis Sci , vol.51 , pp. 2170-2179
    • Sido, B.1    Seel, C.2    Hochlehnert, A.3
  • 76
    • 0032900537 scopus 로고    scopus 로고
    • Inhibition of glutamine synthetase decreases proliferation of cultured rat intestinal epithelial cells
    • DeMarco V, Dyess K, Strauss D et al. Inhibition of glutamine synthetase decreases proliferation of cultured rat intestinal epithelial cells. J Nutr 1999; 129: 57-62.
    • (1999) J Nutr , vol.129 , pp. 57-62
    • DeMarco, V.1    Dyess, K.2    Strauss, D.3
  • 77
    • 0346458628 scopus 로고    scopus 로고
    • Identification of many microRNAs that copurify with polyribomes in mammalian neurons
    • Kim J, Krichevsky A, Grad Y et al. Identification of many microRNAs that copurify with polyribomes in mammalian neurons. Proc Natl Acad Sci USA 2004; 101: 360-5.
    • (2004) Proc Natl Acad Sci USA , vol.101 , pp. 360-365
    • Kim, J.1    Krichevsky, A.2    Grad, Y.3
  • 78
    • 29144505309 scopus 로고    scopus 로고
    • The widespread impact of mammalian microRNA on mRNA repression and evolution
    • Farh KK, Grimson A, Jan C et al. The widespread impact of mammalian microRNA on mRNA repression and evolution. Science 2005; 310: 1817-21.
    • (2005) Science , vol.310 , pp. 1817-1821
    • Farh, K.K.1    Grimson, A.2    Jan, C.3
  • 79
    • 55249119513 scopus 로고    scopus 로고
    • MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2α
    • Wu F, Zikusoka M, Trindade A, Dassopoulus T et al. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2α. Gastroenterology 2008; 135: 1624-35.
    • (2008) Gastroenterology , vol.135 , pp. 1624-1635
    • Wu, F.1    Zikusoka, M.2    Trindade, A.3    Dassopoulus, T.4
  • 80
    • 52949108889 scopus 로고    scopus 로고
    • First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome
    • Kapeller J, Houghton LA, Monnikes H et al. First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome. Hum Mol Genet 2008; 17: 2967-77.
    • (2008) Hum Mol Genet , vol.17 , pp. 2967-2977
    • Kapeller, J.1    Houghton, L.A.2    Monnikes, H.3
  • 81
    • 55549142198 scopus 로고    scopus 로고
    • Increased gastrointestinal permeability and gut inflammation in children with functional abdominal pain and irritable bowel syndrome
    • Schulman RJ, Eakin MN, Czyzewski DJ et al. Increased gastrointestinal permeability and gut inflammation in children with functional abdominal pain and irritable bowel syndrome. J Pediatr 2008; 153: 646-50.
    • (2008) J Pediatr , vol.153 , pp. 646-650
    • Schulman, R.J.1    Eakin, M.N.2    Czyzewski, D.J.3
  • 82
    • 78649743335 scopus 로고    scopus 로고
    • Lactobacillus plantarum ameliorates colonic epithelial barrier dysfunction by modulating the apical junctional complex and PepT1 in IL-10 knockout mice
    • Chen HQ, Yang J, Zhang M et al. Lactobacillus plantarum ameliorates colonic epithelial barrier dysfunction by modulating the apical junctional complex and PepT1 in IL-10 knockout mice. Am J Physiol Gastrointest Liver Physiol 2010; 299: G1287-97.
    • (2010) Am J Physiol Gastrointest Liver Physiol , vol.299
    • Chen, H.Q.1    Yang, J.2    Zhang, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.